ARS Pharmaceuticals (SPRY) Q1 2025 Earnings

20MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.24
0
0.24
0.48

Details

Expected EPS
-0.2375
Actual EPS
0.48
Surprise EPS
0.72
Surprise Percent
+302.11%

Description

ARS Pharmaceuticals (SPRY) has reported earnings of 0.48 per share for Q1 2025.

0 Comments

Share your thoughts